ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2020

Chronic ischaemic heart disease and rivaroxaban: which patients derive the greatest benefit?

Leonardo Bolognese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.